Skip to main content
Year archive

NEUREN PHARMACEUTICALS LIMITED — 2016 filings

All 31 regulatory filings released by NEUREN PHARMACEUTICALS LIMITED (NEU) in 2016, sourced directly from the official regulator.

31 Filings
2016 Period
2016 filings (31)
Filing Released Lang
Results of Meeting 1 page 75.6KB
Declaration of Voting Results & Voting Rights Announcements
2016-12-05 English
Investor presentation, 25 November 2016 23 pages 512.0KB
Investor Presentation
2016-11-24 English
Neuren completes enrolment in Rett syndrome Phase 2 trial 3 pages 122.1KB
Regulatory Filings
2016-11-13 English
Notice of special meeting of shareholders 26 pages 536.6KB
Proxy Solicitation & Information Statement
2016-11-13 English
Appendix 4C - quarterly 6 pages 76.0KB
Interim / Quarterly Report
2016-10-30 English
Appendix 3B 12 pages 108.6KB
Share Issue/Capital Change
2016-10-27 English
Neuren receives $0.9m from exercise of last expiring options 1
Capital/Financing Update
2016-10-27 English
Appendix 3B 12 pages 108.7KB
Capital/Financing Update
2016-08-30 English
Change of Director's Interest Notice 3 pages 80.6KB
Director's Dealing
2016-08-30 English
Half Yearly Report and Accounts 14 pages 473.3KB
Regulatory Filings
2016-08-29 English
Neuren expands Phase 2 Rett syndrome pediatric trial 3 pages 128.1KB
Capital/Financing Update
2016-08-24 English
Appendix 4C - quarterly 5 pages 58.2KB
Interim / Quarterly Report
2016-07-25 English
Neuren presents at Rettsyndrome.org 2016 Research Symposium 17 pages 2.0MB
Investor Presentation
2016-06-23 English
Grant of new patent for Autism Spectrum Disorders 2 pages 107.4KB
Regulatory Filings
2016-06-21 English
Chairman's Address to Shareholders 4 pages 123.6KB
AGM Information
2016-05-30 English
Results of Meeting 1 page 59.9KB
Declaration of Voting Results & Voting Rights Announcements
2016-05-30 English
Change of Director's Interest Notice 3 pages 80.3KB
Director's Dealing
2016-05-15 English
Presentation at 6th Annual TBI Conference, Washington DC 34 pages 497.3KB
Investor Presentation
2016-05-12 English
Notice of Annual General Meeting/Proxy Form 8 pages 469.5KB
AGM Information
2016-05-01 English
Appendix 4C - quarterly 5 pages 58.1KB
Interim / Quarterly Report
2016-04-28 English
Results of Phase 2 trial in moderate to severe TBI 3 pages 120.2KB
Regulatory Filings
2016-04-25 English
Neuren Shareholder Update 2 pages 111.1KB
Capital/Financing Update
2016-04-25 English
Trading Halt 2 pages 324.5KB
Regulatory Filings
2016-04-21 English
Annual Report to shareholders 56 pages 1.5MB
Annual Report
2016-04-17 English
Appendix 4G 11 pages 127.4KB
Governance Information
2016-04-17 English
First subject commences Neuren's Rett syndrome Phase 2 trial 2 pages 108.8KB
Regulatory Filings
2016-04-06 English
Appendix 4E and Financial Report 31 December 2015 31 pages 553.0KB
Annual Report
2016-02-24 English
Neuren reports 2015 full-year financial results 4 pages 146.2KB
Annual Report
2016-02-24 English
Appendix 4C - quarterly 5 pages 57.9KB
Interim / Quarterly Report
2016-01-28 English
Neuren Investor Presentation, 11 January 2016 21 pages 447.3KB
Investor Presentation
2016-01-10 English
Neuren Shareholder Update, January 2016 3 pages 119.7KB
Capital/Financing Update
2016-01-03 English